Background: There is controversy about the outcome of patients with acute myocarditis (AM),
and data are lacking on how patients admitted with suspected AM are managed. We report …

(COVID-19) vaccines have gained widespread use across the globe to prevent further spread
of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. Early studies …

Aims Registries and surveys improve knowledge of the ‘real world’. This paper aims to
describe baseline clinical profiles, management strategies, and the in‐hospital outcome of …

Aims Chronic heart failure (HF) is recognized as an important public health problem but little
attention has been focused on acute-stage HF. Methods and results Nationwide, prospective…

Background Patients with end-stage heart failure are often refractory to maximal oral therapy,
and they have high mortality rates, poor quality of life, and frequent hospitalizations with …

Aims Early recognition of impending decompensation and timely intervention may prevent
heart failure (HF) hospitalization. We investigated the performance of OptiVol ® intrathoracic …

Background— Clinical observational studies on heart failure (HF) deal mostly with hospitalized
patients, few with chronic outpatients, all with no or limited longitudinal observation. …

Background: Previous reports have suggested that despite their dramatic presentation,
patients with fulminant myocarditis (FM) might have better outcome than those with acute …

End of life is an unfortunate but inevitable phase of the heart failure patients' journey. It is often
preceded by a stage in the progression of heart failure defined as advanced heart failure, …

Background : Fulminant myocarditis (FM) is a form of acute myocarditis characterized by
severe left ventricular systolic dysfunction requiring inotropes and/or mechanical circulatory …